MedTrace Logo

Post-Revascularization Optimization and PHysiological Evaluation of intermediaTe Lesions

NCT05056662 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-08-30

No results posted yet for this study

Summary

PROPHET-FFR is a single center ambispective registry aiming to explore the impact of post-revascularization functional assessment on later outcomes.

Conditions

  • Ischemic Heart Disease
  • Angina, Stable
  • Non ST Elevation Myocardial Infarction
  • ST Elevation Myocardial Infarction
  • Unstable Angina
  • Coronary Disease

Interventions

DIAGNOSTIC_TEST

Invasive functional evaluation with either Pd/Pa, FFR, iFR or contrast FFR

Enrolled patients will undergo invasive functional evaluation of coronary stenosis followed by percutaneous revascularization if appropriate. Patients in Group 3 will have target lesion re-assessed using either PdPa, FFR, iFR or contrast FFR.

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    collaborator OTHER

  • Catholic University of the Sacred Heart

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-04
Primary Completion
2025-06-04
Completion
2025-10-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05056662 on ClinicalTrials.gov